Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

Chamie-Quintero et al., Preprint, doi:10.2139/ssrn.3765018
Jan 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now known with p < 0.00000000001 from 100 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19ivm.org
Analysis of ivermectin usage within states in Peru showing sharp reductions in COVID-19 deaths corresponding to the usage of ivermectin treatment.
Chamie-Quintero et al., 21 Jan 2021, preprint, 3 authors.
This PaperIvermectinAll
Sharp reductions in COVID-19 case fatalities and excess deaths in Peru in close time conjunction, state-by-state, with ivermectin treatments
Juan J Chamie-Quintero, Jennifer A Hibberd, PhD David E Scheim
A) Excess all-cause deaths; B) COVID-19 case fatalities; and C) case incidence data for eight states in Peru that deployed mass ivermectin (IVM) treatments early in their pandemic spread (blue) and for Lima, which deployed IVM treatment four months later (red). D) Excess deaths for nine states having mass IVM distributions in a short period through national operation "MOT" (see results section for sources). • MOT start date; ▲peak deaths; ■ day of peak deaths + 30 days. Junin (yellow) distributed IVM to health centers beginning on July 22, 13 days before MOT start. Population-weighted mean deaths for these nine states dropped sharply, -74% at +30 days, beginning (except for Junin) 1 to 11 days after MOT start. All y values are 7-day moving averages, ages ≥ 60.
Supplementary information is retrievable at https://drive.google.com/file/d/1bjm62m0NwL_1cGPSYyQjjgu3Xas0rkSR/view?usp=sharing
References
Alam, Murshed, Bhiuyan, A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline, Journal of Bangladesh College of Physicians and Surgeons
Arseculeratne, Arseculeratne, A re-appraisal of the conventional history of antibiosis and Penicillin, Mycoses
Award Ceremony ; Dr, Omura, None
Badhan, Zakaria, Olafuyi, The Repurposing of Ivermectin for Malaria: A Prospective Pharmacokinetics-Based Virtual Clinical Trials Assessment of Dosing Regimen Options, Journal of Pharmaceutical Sciences
Badr, Du, Marshall, Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study, The Lancet Infectious Diseases
Baker, Richards, Guy, The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device, ACS Central Science
Bennett, Chung, Alexander Fleming and the discovery of penicillin, Advances in Applied Microbiology
Cabezas, Fiestas, García-Mendoza, Dengue en el Perú: a un cuarto de siglo de su reemergencia, Revista Peruana de Medicina Experimental y Salud Publica
Caly, Druce, Catton, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Res
Carvallo, Hirsch, Farinella, Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19, medRxiv, doi:10.1101/2020.09.10.20191619
Cenares, Ministerio de Salud de Peru
Chaccour, Casellas, Blanco-Di Matteo, The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial, EClinicalMedicine
Chen, Liu, Liu, A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19), J Zhejiang Univ (Med Sci)
Chowdhury, Shahbaz, Karim, A comparative study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients
Condezo, Facebook
Corsig, Soloway, Stanaro, Glaxo Holdings PLC: Zantac
Crump, Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations, J Antibiot
Cruz, Testimonio del Sub Oficial Darvin Condezo
Dai, Gao, Viral targets for vaccines against COVID-19, Nature Reviews Immunology
Dayer, Coronavirus (2019-nCoV) Deactivation via Spike Glycoprotein Shielding by Old Drugs, Bioinformatic Study, doi:10.20944/preprints202005.0020.v1
Dr, Fernando Massé sobre la ivermectina
Dr, Massé indicó en qué momento es más efectiva consumir ivermectina
Dr, Omura, lecture at the Showa Pharmaceutical University
Elgzazzar, Hany, Youssef, Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic, Research Square, doi:10.21203/rs.3.rs-100956/v1
Epdsesa, Covid-19: a más de 22,000 personas atendió Operación Tayta-Yo Me Apunto en Cajamarca
Espitia-Hernandez, Munguia, Diaz-Chiguer, Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on COVID-19 infected patients: A proof of concept study, Biomedical Research
Florey, Adelaide, Florey, General and local administration of penicillin, The Lancet
Fonseca, Exclusive, Study suggests dengue may provide some immunity against COVID-19
George, Borody, Andrews, Cure of duodenal ulcer after eradication of Helicobacter pylori, Med J Aust
Gorial, Mashhadani, Sayaly, Effectiveness of Ivermectin as add-on Therapy in COVID-19
Greaney, Loes, Crawford, Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies, bioRxiv, doi:10.1101/2020.12.31.425021
Greaney, Starr, Gilchuk, Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition, Cell Host & Microbe
Guzzo, Furtek, Porras, Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects, J Clin Pharmacol
Hashim, Maulood, Rasheed, Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq, doi:10.1101/2020.10.26.20219345
Hussien, Abdelaziz, Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease, Network Modeling Analysis in Health Informatics and Bioinformatics
Ietsi, None, Instituto de Evaluación de Tecnologías en Salud e Investigación
Juscamayta-López, Tarazona, Valdivia, Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru, bioRxiv, doi:10.1101/2020.09.14.296814
Kalhor, Sadeghi, Abolhasani, Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches, Journal of Biomolecular Structure and Dynamics
Keefer, Blake, Marshall, Penicillin in the treatment of infections; 500 cases, Journal of the American Medical Association
Kingston, Antibiotics, invention and innovation, Research Policy
Krolewiecki, Lifschitz, Moragas, Antiviral effect of high-dose ivermectin in adults with COVID-19: a pilot randomised, controlled, open label, multicentre trial
Lam, Murphy, Kuri-Cervantes, Erythrocytes Reveal Complement Activation in Patients with COVID-19, medRxiv, doi:10.1101/2020.05.20.20104398
Lawrence, Sodahlon, Ogoussan, Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control, PLoS Negl Trop Dis
Lehrer, Rheinstein, Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2, Vivo
Ligon, Penicillin: its discovery and early development, Seminars in Pediatric Infectious Diseases
Llantoy, Mediante empadronamiento ejecutado por 60 brigadistas de la mph y "amachay
Luna, Repartirán 10 mil kits con Ivermectina para combatir Covid-19 en Tuxtla
Lyons, Penicillin therapy of surgical infections in the US Army: A report, Journal of the American Medical Association
Marshall, Goodwin, Warren, Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori, Lancet
Marshall, Helicobacter Connections
Marshall, Nobel Prize biography
Martín De Porres, incautan 20,000 frascos de ivermectina y detienen a 12 personas
Maurya, A Combination of Ivermectin and Doxycycline Possibly Blocks the Viral Entry and Modulate the Innate Immune Response in COVID-19 Patients, ChemRxiv, doi:10.26434/chemrxiv.12630539.v1
Minsa, Casos confirmados por coronavirus Covid-19 ascienden a 818 297 en el Perú
Modrof, Kerschbaum, Farcet, SARS-CoV-2 and the safety margins of cell-based biological medicinal products, Biologicals
Momekov, Momekova, Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens, Biotechnology & Biotechnological Equipment
Moquegua, llegan otros 45 médicos desde Lima para reforzar lucha contra el coronavirus
Muik, Wallisch, Sänger, Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera, bioRxiv, doi:10.1101/2021.01.18.426984
Munnangi, Sonnenberg, Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States, Arch Intern Med
Nallusamy, Mannu, Ravikumar, Shortlisting Phytochemicals Exhibiting Inhibitory Activity against Major Proteins of SARS-CoV-2 through Virtual Screening, Research Square, doi:10.21203/rs.3.rs-31834/v1
Niaee, Gheibi, Namdar, Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients; A randomized multi-center clinical trial, Research Square, doi:10.21203/rs.3.rs-109670/v1
Nicolas, Maia, Bassat, Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis, The Lancet Global Health
O'donohue, Lilienfeld, Professional issues and evidence-based practice: The quality problem in behavioral health care, doi:10.1002/9781118156391
Offord, Surgisphere Sows Confusion About Another Unproven COVID-19 Drug, The Scientist
Oh, Lee, Long, How well does societal mobility restriction help control the COVID-19 pandemic? Evidence from real-time evaluation, medRxiv, doi:10.1101/2020.10.29.20222414
Piura, Detienen a dos personas con más de 200 dosis de ivermectina de contrabando; coronavirus; COVID-19
Polack, Thomas, Kitchin, Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (study protocol), N Engl J Med
Polack, Thomas, Kitchin, Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, N Engl J Med
Prof, None
Puno, Desde mañana implementarán la operación Tayta liderado por el Ejército peruano
Rajter, Sherman, Fatteh, Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19, ICON study, doi:10.1016/j.chest.2020.10.009
Richards, Production of Penicillin in the United States (1941-1946), Nature
Rojas, Amaya, Grupo de médicos recomiendan descontinuar uso no supervisado de hidroxicloroquina e ivermectina
Scheim, From cold to killer: How SARS-CoV-2 evolved without hemagglutinin esterase to agglutinate, then clot blood cells in pulmonary and systemic microvasculature
Scheim, Ivermectin for COVID-19 treatment: clinical response at quasi-threshold doses via hypothesized alleviation of CD147-mediated vascular occlusion
Schmith, Zhou, Lohmer, The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19, Clin Pharmacol Ther
Shouman, Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close Contacts with Patients of COVID
Stokes, Turner, Anselmi, The relative effects of non-pharmaceutical interventions on early Covid-19 mortality: natural experiment in 130 countries, medRxiv, doi:10.1101/2020.10.05.20206888
Suravajhala, Parashar, Malik, Comparative Docking Studies on Curcumin with COVID-19 Proteins, doi:10.20944/preprints202005.0439.v2
Unwin, Mishra, Bradley, State-level tracking of COVID-19 in the United States, Nature Communications
Weisblum, Schmidt, Zhang, Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants, eLife
Welsh, Inequality and corruption: Why Peru is losing its COVID-19 battle, Devex
Wendler, Ochoa, Millum, COVID-19 vaccine trial ethics once we have efficacious vaccines, Science
Wibmer, Ayres, Hermanus, SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma, bioRxiv, doi:10.1101/2021.01.18.427166
Wu, Werner, Moliva, mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants, bioRxiv
Yumbato, Coronavirus en Perú: Experiencia médica funcionó en pacientes peruanos
Yumbato, Coronavirus en Perú: conoce cómo funciona la Operación Tayta
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit